title: Merck VIOXX "warning" is questioned.
authors.forename: T Scott
authors.initials: TS
authors.lastname: Allen
authors.forename: Jay H
authors.initials: JH
authors.lastname: Henderson
mesh_terms: D002986:Clinical Trials as Topic; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D004348:Drug Labeling; D006801:Humans; D007783:Lactones / Q000009:adverse effects*; D008318:Malpractice / Q000331:legislation & jurisprudence; D009203:Myocardial Infarction / Q000139:chemically induced*; D010820:Physicians; D013450:Sulfones / Q000009:adverse effects*
chemical_list: D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib